SEC Company Response from HOOKIPA Pharma Inc. (HOOK) (CIK 0001760542) (HOOK) — Apr 12, 2019
HOOKIPA Pharma Inc. (HOOK) (CIK 0001760542)
Date: April 12, 2019 · CIK: 0001760542 · Accession: 0001104659-19-021118
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230451
Letter
Re: HOOKIPA Pharma Inc.
April 12, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (as amended) (SEC File No. 333-230451)
Ladies and Gentlemen:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of HOOKIPA Pharma Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., New York City time, on April 17, 2019, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 1,480 copies of the Preliminary Prospectus dated April 8, 2019 through the date hereof, to underwriters, dealers, institutions and others.
In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended.
Very truly yours,
MERRILL LYNCH, PIERCE, FENNER & SMITH
Show Raw Text
CORRESP 1 filename1.htm April 12, 2019 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: HOOKIPA Pharma Inc. Registration Statement on Form S-1 (as amended) (SEC File No. 333-230451) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of HOOKIPA Pharma Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., New York City time, on April 17, 2019, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, please be advised that we have distributed approximately 1,480 copies of the Preliminary Prospectus dated April 8, 2019 through the date hereof, to underwriters, dealers, institutions and others. In connection with the Preliminary Prospectus distribution for the above-referenced issue, the prospective underwriters have confirmed that they are complying with the 48-hour requirement in Rule 15c2-8(b) under the Securities Exchange Act of 1934, as amended. Very truly yours, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED SVB LEERINK LLC RBC CAPITAL MARKETS, LLC As Representatives of the several underwriters [SIGNATURE PAGES FOLLOW] MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED By: /s/ Michael Liloia Name: Michael Liloia Title: Director SVB LEERINK LLC By: /s/ Stuart R. Nayman Name: Stuart R. Nayman Title: Managing Director, Senior Legal Counsel RBC CAPITAL MARKETS, LLC By: /s/ John Reed Name: John Reed Title: Managing Director As representatives of the several underwriters. cc: Ilir Mujalovic, Partner, Shearman & Sterling LLP [Signature Page to Acceleration Request Letter]